Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bukit Uluwatu Villa Tbk (BUVA) vs Merck Tbk. (MERK) Price & Performance

Bukit Uluwatu Villa TbkTrade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Bukit Uluwatu Villa Tbk vs Merck Tbk. — how do they compare? Bukit Uluwatu Villa Tbk trades at Rp725 (market cap 17.85T, 79.86M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Bukit Uluwatu Villa Tbk is far larger — about 10.2× Merck Tbk.'s market cap, and Bukit Uluwatu Villa Tbk is more actively traded (79.86M versus 29.1K). Which is the better fit depends on your goals.

BUVAMERK
Market Cap
17.85T1.75T
Volume
79.86M29.1K
Lot
798.6K291
Turnover
57.14B113.37M
Average Price
715.513,895.98
Value
57.14B113.37M
Indicative Equilibrium Price
7253,890
Indicative Equilibrium Volume
15.29K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BUVA
View details
MERK
View details

About Bukit Uluwatu Villa Tbk

PT Bukit Uluwatu Villa Tbk (the “Company”) was established in the Republic of Indonesia on December 15, 2000 based on the Notarial Deed No. 53 of Sugito Tedjamulja, S.H.. The Company’s status has been changed from foreign investment company (PMA) to domestic investment company (PMDN).

Read more on BUVA

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK